KREBSBIOMARKER

European patent · EP3524697 · In force

Register entry

Publication number
EP3524697
Application number
EP18209293
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 7, 2010
Published
Aug 14, 2019
Granted
Oct 2, 2024
Protection ends at the latest
Jan 6, 2030
Next annual fee due
Jan 31, 2027
IPC classes
C12Q 1/6886 (2018.01)
G01N 33/574 (2006.01)
Priority
US 14307709 P 07.01.2009
US 17965009 P 19.05.2009
US 18590109 P 10.06.2009
US 24174809 P 11.09.2009
US 25644309 P 30.10.2009
Divided from
EP16170659
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  2. Aug 13, 2025

    Change

    Published in Swissreg on 13.08.2025

  3. Feb 1, 2025

    Change

    Published in Swissreg on 01.02.2025

  4. Nov 13, 2024

    Agent entered

    Representative
    BOVARD AG, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 13.11.2024

  5. Oct 3, 2024

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 03.10.2024

Parties

Holder

Myriad Genetics, Inc.

320 Wakara Way, Salt Lake City, UT 84108, US

Agent

Bovard AG

BOVARD AG

Optingenstrasse 16, 3013 Bern

Inventor

Stone, Steve

Salt Lake City, UT 84108, US

Gutin, Alexander

Salt Lake City, UT 84108, US

Wagner, Susanne

Salt Lake City, UT 84108, US

Reid, Jutta

Salt Lake City, UT 84108, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.